University of Texas M D Anderson Cancer Center Cytopathology

Topics

• Breast Cancer Treatment Studies 288
• Breast Lesions and Carcinomas 118
• Cancer Genomics and Diagnostics 76
• Thyroid Cancer Diagnosis and Treatment 74
• Salivary Gland Tumors Diagnosis and Treatment 63
• HER2/EGFR in Cancer Research 62
• Lung Cancer Treatments and Mutations 56
• Cancer Immunotherapy and Biomarkers 50
• Bladder and Urothelial Cancer Treatments 47
• Cervical Cancer and HPV Research 45
• Lung Cancer Diagnosis and Treatment 41
• Lymphoma Diagnosis and Treatment 40

Most cited

1. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.

   Cell · 2024 · 464 citations · Sinchita Chowdhuri

2. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 841 citations · William Symmans

3. Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2026 · 56 citations · William Symmans

4. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

   The Lancet. Oncology · 2022 · 422 citations · William Symmans

5. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

   Nature medicine · 2021 · 558 citations · Neda Kalhor

6. Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology.

   Archives of pathology & laboratory medicine · 2022 · 169 citations ·